Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Embryonal Tumor With Multilayered Rosettes: early-phase trial registry
4 of 4 indexed Embryonal Tumor With Multilayered Rosettes trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Embryonal Tumor With Multilayered Rosettes: 4 US clinical trials tracked, 4 recruiting.
Embryonal Tumor With Multilayered Rosettes is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Hackensack Meridian Health, running 1 of these trials.
Enrollment posture brief
Registry condition embryonal-tumor-with-multilayered-rosettes
OPEN 4 | RECR 100% | LATE 0 | EARLY 3 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Embryonal Tumor With Multilayered Rosettes lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Embryonal Tumor With Multilayered Rosettes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Embryonal Tumor With Multilayered Rosettes is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Milton S. Hershey Medical Center
NCT06465199
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
Hackensack Meridian Health
NCT04794686
Embryonal Tumor With Multilayered Rosettes
University of California, San Francisco
NCT06861244
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Children's National Research Institute
NCT06193759
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Embryonal Tumor With Multilayered Rosettes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Embryonal Tumor With Multilayered Rosettes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Embryonal Tumor With Multilayered Rosettes page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Embryonal Tumor With Multilayered Rosettes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Hackensack Meridian Health sponsors the most Embryonal Tumor With Multilayered Rosettes trials on record, review their full trial history before evaluating a specific study. See Hackensack Meridian Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Embryonal Tumor With Multilayered Rosettes condition card totals 4 registered trials; most-linked intervention Eflornithine (DFMO); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.